Metasphere Labs Inc. LABZ
CNSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -109.19% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -109.19% | -- |
| Cost of Revenue | -- | -- | -- | -154.12% | -- |
| Gross Profit | -- | -- | -- | -100.60% | -- |
| SG&A Expenses | -66.93% | -17.10% | -59.71% | -52.94% | -36.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -60.65% | -31.39% | -62.85% | -63.16% | -55.85% |
| Operating Income | 60.65% | 16.18% | 62.85% | 26.91% | -272.17% |
| Income Before Tax | 50.52% | 16.21% | 62.73% | 72.55% | -201.46% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 50.52% | 16.21% | 62.73% | 72.55% | -201.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.52% | 16.21% | 62.73% | 72.55% | -201.46% |
| EBIT | 60.65% | 16.18% | 62.85% | 26.91% | -272.17% |
| EBITDA | -- | -- | -- | 27.49% | -229.71% |
| EPS Basic | 67.97% | 21.05% | 67.80% | 80.06% | -202.68% |
| Normalized Basic EPS | 67.71% | 20.83% | 68.24% | 54.79% | -292.00% |
| EPS Diluted | 67.97% | 21.05% | 67.80% | 80.06% | -244.34% |
| Normalized Diluted EPS | 67.71% | 20.83% | 68.24% | 54.79% | -374.29% |
| Average Basic Shares Outstanding | 53.07% | 5.86% | 16.05% | 37.40% | -0.83% |
| Average Diluted Shares Outstanding | 53.07% | 5.86% | 16.05% | 37.40% | -29.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |